Expression of CD46 is low in normal cells, but is upregulated in human cancer cells such as ovarian cancer, breast cancer, lymphoma, hepatocellular carcinoma, lung cancer, prostate cancer, and colon cancer, presumably to protect the cancer cells from the complement system [19,22,23,24,25,26,27]. This evidence concerns the gene CD46 and cancer.